Joel Lewis
2021
In 2021, Joel Lewis earned a total compensation of $1.2M as Chief Executive Officer & President at Galectin Therapeutics, a 55% increase compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Option Awards | $329,177 |
| Salary | $500,000 |
| Other | $88,444 |
| Total | $1,167,621 |
Lewis received $500K in salary, accounting for 43% of the total pay in 2021.
Lewis also received $250K in bonus, $329.2K in option awards and $88.4K in other compensation.
Rankings
In 2021, Joel Lewis' compensation ranked 8,222nd out of 12,415 executives tracked by ExecPay. In other words, Lewis earned more than 33.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,222 out of 12,415 | 34th |
Division Manufacturing | 3,638 out of 5,505 | 34th |
Major group Chemicals And Allied Products | 1,619 out of 2,375 | 32nd |
Industry group Drugs | 1,439 out of 2,096 | 31st |
Industry Pharmaceutical Preparations | 1,070 out of 1,546 | 31st |
Source: SEC filing on October 17, 2022.
Lewis' colleagues
We found two more compensation records of executives who worked with Joel Lewis at Galectin Therapeutics in 2021.